Tuesday, November 12, 2013
In this video, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists (IACP), discusses H.R. 3204, the Drug Quality and Security Act
, which passed the House of Representatives on September 25, 2013. Miller explains that IACP opposes the bill because it reaffirms section 503A of the Federal Food, Drug, and Cosmetic Act rather than fixing its problems. This video was recorded at the National Community Pharmacists Association 115th Annual Convention in Orlando.